Future prospects and challenges for Alzheimer's disease drug development in the era of the NIA-AA Research Framework

Ara S. Khachaturian, Kathleen M. Hayden, Michelle M. Mielke, Yi Tang, Michael W. Lutz, Deborah R. Gustafson, Walter A. Kukull, Richard Mohs, Zaven S. Khachaturian

Research output: Contribution to journalEditorial

20 Scopus citations
Original languageEnglish (US)
Pages (from-to)532-534
Number of pages3
JournalAlzheimer's and Dementia
Volume14
Issue number4
DOIs
StatePublished - Apr 2018

ASJC Scopus subject areas

  • Epidemiology
  • Health Policy
  • Developmental Neuroscience
  • Clinical Neurology
  • Geriatrics and Gerontology
  • Psychiatry and Mental health
  • Cellular and Molecular Neuroscience

Cite this

Khachaturian, A. S., Hayden, K. M., Mielke, M. M., Tang, Y., Lutz, M. W., Gustafson, D. R., Kukull, W. A., Mohs, R., & Khachaturian, Z. S. (2018). Future prospects and challenges for Alzheimer's disease drug development in the era of the NIA-AA Research Framework. Alzheimer's and Dementia, 14(4), 532-534. https://doi.org/10.1016/j.jalz.2018.03.003